Literature DB >> 22883659

Malignant struma ovarii: the west of Scotland experience and review of literature with focus on postoperative management.

Raj K Shrimali1, Ghazia Shaikh, Nick S Reed.   

Abstract

INTRODUCTION: Malignant struma ovarii is an extremely rare ovarian tumour containing malignant thyroid carcinoma within differentiated thyroid tissue, as the predominant tissue type. Surgery for suspected ovarian tumour and incidental pathological diagnosis is the most common presentation. Evidence supporting any particular approach to the clinical management of this condition is limited, mainly consisting of case reports, small series or pathological case series. There is no randomised evidence for postoperative management in view of the rarity of this condition. The opinion is divided between conservative management versus total thyroidectomy and radio-iodine ablation.
METHODS: We carried out a retrospective review of our series with focus on postoperative management of this rare condition. A review of existing literature was also carried out.
RESULTS: Six patients with a median age of 52 years presented with various symptoms of abdominal pain, pressure or menstrual problems. After the initial gynaecological resection and specialised pathology review, they were subsequently treated with total thyroidectomy and administration of radioactive iodine. All of these six patients are in remission at a median follow up of 60 months.
CONCLUSION: We favour aggressive postoperative management with total thyroidectomy and radioactive iodine, and long-term follow up of these patients.
© 2012 The Authors. Journal of Medical Imaging and Radiation Oncology © 2012 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Mesh:

Year:  2012        PMID: 22883659     DOI: 10.1111/j.1754-9485.2012.02394.x

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  6 in total

1.  Usefulness of (131)I-SPECT/CT and (18)F-FDG PET/CT in Evaluating Successful (131)I and Retinoic Acid Combined Therapy in a Patient with Metastatic Struma Ovarii.

Authors:  Hyo Jung Seo; Young Hoon Ryu; Inki Lee; Hye Sook Min; Keon Wook Kang; Dong Soo Lee; Dae-Hee Lee; June-Key Chung
Journal:  Nucl Med Mol Imaging       Date:  2014-09-25

2.  Rare ovarian tumours. Other treatments for ovarian cancer.

Authors:  Marta Gil-Martin; Beatriz Pardo; Maria-Pilar Barretina-Ginesta
Journal:  EJC Suppl       Date:  2020-08-22

Review 3.  Case Report: Recurrent Malignant Struma Ovarii With Hyperthyroidism and Metastases, A Rare Case Report and Review of the Literature.

Authors:  Ruyi Zhang; Xin Tian; Ying Luo; Haiwei Dong; Weijun Tian; Yujie Zhang; Dong Li; Haoran Sun; Zhaowei Meng
Journal:  Pathol Oncol Res       Date:  2022-05-10       Impact factor: 2.874

4.  The largest reported papillary thyroid carcinoma arising in struma ovarii and metastasis to opposite ovary: case report and review of literature.

Authors:  Mohamed S Al Hassan; Tamer Saafan; Walid El Ansari; Afaf A Al Ansari; Mahmoud A Zirie; Hanan Farghaly; Abdelrahman Abdelaal
Journal:  Thyroid Res       Date:  2018-07-24

5.  Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary.

Authors:  Sijian Li; Tengyu Yang; Yang Xiang; Xiaoyan Li; Limeng Zhang; Shan Deng
Journal:  BMC Cancer       Date:  2021-04-09       Impact factor: 4.430

6.  Synchronous papillary carcinoma thyroid with malignant struma ovarii: A management dilemma.

Authors:  Arvind Krishnamurthy; Vijayalakshmi Ramshankar; Venkatesh Vaidyalingam; Urmila Majhi
Journal:  Indian J Nucl Med       Date:  2013-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.